CN1374126A - 一种用于清热解毒的药物及其制备方法 - Google Patents
一种用于清热解毒的药物及其制备方法 Download PDFInfo
- Publication number
- CN1374126A CN1374126A CN 02114995 CN02114995A CN1374126A CN 1374126 A CN1374126 A CN 1374126A CN 02114995 CN02114995 CN 02114995 CN 02114995 A CN02114995 A CN 02114995A CN 1374126 A CN1374126 A CN 1374126A
- Authority
- CN
- China
- Prior art keywords
- medicine
- injection
- add
- herba artemisiae
- artemisiae annuae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 231100000331 toxic Toxicity 0.000 title abstract description 4
- 230000002588 toxic effect Effects 0.000 title abstract description 4
- 229940079593 drug Drugs 0.000 title description 13
- 239000000463 material Substances 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 25
- 238000002347 injection Methods 0.000 claims abstract description 24
- 239000007924 injection Substances 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000341 volatile oil Substances 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 5
- 238000010992 reflux Methods 0.000 claims abstract description 5
- 239000008215 water for injection Substances 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 20
- 239000006071 cream Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 231100000614 poison Toxicity 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000003440 toxic substance Substances 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 238000012546 transfer Methods 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 5
- 239000003708 ampul Substances 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 4
- -1 filter Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 240000001972 Gardenia jasminoides Species 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 4
- 235000001405 Artemisia annua Nutrition 0.000 abstract 4
- 240000000011 Artemisia annua Species 0.000 abstract 4
- 244000111489 Gardenia augusta Species 0.000 abstract 4
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 4
- 229960000502 poloxamer Drugs 0.000 abstract 1
- 229920001983 poloxamer Polymers 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 230000001047 pyretic effect Effects 0.000 description 10
- 231100000419 toxicity Toxicity 0.000 description 10
- 230000001988 toxicity Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 230000000840 anti-viral effect Effects 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 206010022000 influenza Diseases 0.000 description 7
- 206010035664 Pneumonia Diseases 0.000 description 6
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 206010006451 bronchitis Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010020741 Hyperpyrexia Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 201000009240 nasopharyngitis Diseases 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000010753 nasal discharge Diseases 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 210000001163 endosome Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- JJBCTCGUOQYZHK-ZSCHJXSPSA-N 2-acetyloxybenzoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.CC(=O)OC1=CC=CC=C1C(O)=O JJBCTCGUOQYZHK-ZSCHJXSPSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000031636 Body Temperature Changes Diseases 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000008923 Qingkailing Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 229960004105 carbasalate calcium Drugs 0.000 description 1
- VYMUGTALCSPLDM-UHFFFAOYSA-L carbasalate calcium Chemical compound [Ca+2].NC(N)=O.CC(=O)OC1=CC=CC=C1C([O-])=O.CC(=O)OC1=CC=CC=C1C([O-])=O VYMUGTALCSPLDM-UHFFFAOYSA-L 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- VYQRBKCKQCRYEE-UHFFFAOYSA-N ctk1a7239 Chemical compound C12=CC=CC=C2N2CC=CC3=NC=CC1=C32 VYQRBKCKQCRYEE-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N phenyl acetate Chemical compound CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000009254 shuang-huang-lian Substances 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
病例号 | 性别 | 年龄 | 诊断 | 用药前主要症状 | 用药效果 | 治疗天数 |
2 | 男 | 22岁 | 急性上呼吸道感染 | 发热T38.9℃:恶风、头痛、咽干痛、口渴、扁桃体II度肿大。听两肺呼吸音粗糙,WBC、DBC升高。 | 体温恢复正常,症状消失,WCB+DBC恢复正常 | 2天 |
7 | 女 | 31岁 | 流感 | 头痛畏寒、发热T40℃ 腰背四肢酸痛、乏力、干咳咽痛、流涕、听两肺呼吸音粗、WBC↑L↑ | 体温基本恢复正常,理化检查无异常,仍感乏力。 | 3天 |
13 | 女 | 13岁 | 急性支气管炎 | 鼻寒流涕、咳嗽、气急、咯痰稀白、发热T38.6℃ 听两肺呼吸音粗糙,WBC、DBC↑。 | 体温基本恢复正常,仍时咳嗽、吐痰,其它症状消失 | 3天 |
18 | 男 | 62岁 | 肺炎 | 发热T39.1℃、咳嗽气促、吐黄痰、听两肺可细温WBC、DBC↑ | 体温较前降低,其它症状较前减轻 | 3天 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02114995 CN1129450C (zh) | 2002-03-22 | 2002-03-22 | 一种用于清热解毒的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02114995 CN1129450C (zh) | 2002-03-22 | 2002-03-22 | 一种用于清热解毒的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1374126A true CN1374126A (zh) | 2002-10-16 |
CN1129450C CN1129450C (zh) | 2003-12-03 |
Family
ID=4743400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02114995 Expired - Lifetime CN1129450C (zh) | 2002-03-22 | 2002-03-22 | 一种用于清热解毒的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1129450C (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101045099B (zh) * | 2006-03-27 | 2011-07-06 | 江苏康缘药业股份有限公司 | 一种治疗高热抽搐的中药组合物 |
CN101721515B (zh) * | 2008-10-28 | 2012-10-03 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗手口足病药物中的应用 |
CN103655817A (zh) * | 2013-11-20 | 2014-03-26 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗急、慢性肝损伤药物中的应用 |
CN105341922A (zh) * | 2015-11-24 | 2016-02-24 | 冯林 | 清热解毒速溶粉及其制备方法 |
CN105687401A (zh) * | 2014-11-25 | 2016-06-22 | 哈药集团中药二厂 | 一种由青蒿、栀子、金银花组成的中药组合物及其制备鼻腔冲洗剂的方法 |
CN108434219A (zh) * | 2018-06-12 | 2018-08-24 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗或预防中耳炎药物中的应用 |
CN108434218A (zh) * | 2018-06-08 | 2018-08-24 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗或预防黄疸药物中的应用 |
CN108452054A (zh) * | 2018-06-08 | 2018-08-28 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗或预防百日咳药物中的应用 |
CN108553534A (zh) * | 2018-06-27 | 2018-09-21 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备脓毒血症药物中的应用 |
CN111643649A (zh) * | 2020-05-20 | 2020-09-11 | 博奥生物集团有限公司 | 防治免疫相关疾病的中药材及其组合物 |
WO2022022020A1 (zh) * | 2020-07-30 | 2022-02-03 | 江苏康缘药业股份有限公司 | 一种中药组合物、制备方法及应用 |
CN114533813A (zh) * | 2022-02-16 | 2022-05-27 | 岳阳市中医医院 | 一种抗菌抗病毒的中药组合物及其制备方法 |
-
2002
- 2002-03-22 CN CN 02114995 patent/CN1129450C/zh not_active Expired - Lifetime
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101045099B (zh) * | 2006-03-27 | 2011-07-06 | 江苏康缘药业股份有限公司 | 一种治疗高热抽搐的中药组合物 |
CN101721515B (zh) * | 2008-10-28 | 2012-10-03 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗手口足病药物中的应用 |
CN103655817A (zh) * | 2013-11-20 | 2014-03-26 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗急、慢性肝损伤药物中的应用 |
CN105687401A (zh) * | 2014-11-25 | 2016-06-22 | 哈药集团中药二厂 | 一种由青蒿、栀子、金银花组成的中药组合物及其制备鼻腔冲洗剂的方法 |
CN105341922A (zh) * | 2015-11-24 | 2016-02-24 | 冯林 | 清热解毒速溶粉及其制备方法 |
CN108434218A (zh) * | 2018-06-08 | 2018-08-24 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗或预防黄疸药物中的应用 |
CN108452054A (zh) * | 2018-06-08 | 2018-08-28 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗或预防百日咳药物中的应用 |
CN108434219A (zh) * | 2018-06-12 | 2018-08-24 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备治疗或预防中耳炎药物中的应用 |
CN108553534A (zh) * | 2018-06-27 | 2018-09-21 | 江苏康缘药业股份有限公司 | 一种中药组合物在制备脓毒血症药物中的应用 |
CN111643649A (zh) * | 2020-05-20 | 2020-09-11 | 博奥生物集团有限公司 | 防治免疫相关疾病的中药材及其组合物 |
WO2022022020A1 (zh) * | 2020-07-30 | 2022-02-03 | 江苏康缘药业股份有限公司 | 一种中药组合物、制备方法及应用 |
CN114533813A (zh) * | 2022-02-16 | 2022-05-27 | 岳阳市中医医院 | 一种抗菌抗病毒的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1129450C (zh) | 2003-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5336656B2 (ja) | 気管支炎を治療するための麻黄含有医薬組成物およびその調製方法 | |
CN1899550A (zh) | 一种治疗小儿寒型咳嗽的外贴膏及其制备方法 | |
CN103169891B (zh) | 一种新型维c银翘片 | |
CN100546620C (zh) | 一种治疗呼吸道疾病的中药及其制备方法 | |
CN1129450C (zh) | 一种用于清热解毒的药物及其制备方法 | |
CN112353855A (zh) | 中药组合物在制备辅助治疗新型冠状病毒肺炎的药物中的应用 | |
CN102319294B (zh) | 双香草制剂及其制备方法 | |
CN111214550A (zh) | 药物在治疗或预防新型冠状病毒肺炎2019-nCoV中的新用途 | |
CN116139237B (zh) | 一种防治新型冠状病毒等所致呼吸道感染的中药组合物及其应用 | |
CN101322749B (zh) | 一种治疗风热感冒的中药口服液及其制备方法 | |
CN104127542B (zh) | 一种治疗小儿反复上呼吸道感染的药物组合物 | |
CN103830609B (zh) | 一种治疗咳嗽咳痰的中药制剂 | |
CN106075229A (zh) | 一种治疗风热感冒的中药组合物制剂 | |
CN1931262A (zh) | 一种治疗感冒的中药制剂 | |
CN101785804B (zh) | 一种治疗急性黄疸型肝炎的药物 | |
CN1233408C (zh) | 一种治疗咽炎疾病的利咽喉片药及其制备方法 | |
CN1533795A (zh) | 一种治疗消化性溃疡的中药及其制法 | |
CN100457177C (zh) | 一种清肺、补肾的中药保健制剂 | |
CN101336954A (zh) | 一种治疗感冒的药物组合物及其制备方法 | |
CN101549051A (zh) | 一种治疗哮喘的中药组合物及其制备方法 | |
CN106110029A (zh) | 一种治疗皮肤过敏的外用药膏及制备方法 | |
CN1092976C (zh) | 苦荬菜在制备治疗结核病药物方面的用途 | |
CN115814006A (zh) | 固工蝉菊鼻炎丸 | |
CN105288202A (zh) | 一种治疗小儿咳嗽的药物组合物 | |
CN1259938C (zh) | 一种治疗咳嗽的中药复方制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KANGYUAN PHARMACEUTICAL CO., LTD., JIANGSU PROV. Free format text: FORMER OWNER: ZHANG PING Effective date: 20050114 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20050114 Address after: 222001 Jiangsu Province, Lianyungang city Sinpo District Haichang Road No. 58 Patentee after: Kangyuan Pharmceutical Co., Ltd. Address before: 510610 Guangdong city of Guangzhou province forest and Road No. 150, Room 802 on the eighth floor of Tianyu Garden Plaza Accord Patentee before: Zhang Ping |
|
CX01 | Expiry of patent term |
Granted publication date: 20031203 |
|
CX01 | Expiry of patent term |